Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Nat Rev Neurol 15(10):565581
Efficacy and safety of upadacitinib in patients with giant cell arteritis (SELECT-GCA): a double-blind, randomized controlled phase 3 trial [abstract]
Quality Assurance & Batch Documentation Current USCL 070626 documents are centralized below and retained in the COA, HPLC, and MS tabs
US$ 26.00
US$ 29.92
US$ 21.70
US$ 21.37
US$ 23.78
US$ 21.65
